HCAT

Health Catalyst, Inc.

Healthcare · $129M market cap

We can't put a fair value on HCAT right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?

Equity per share growth-17.8% a year✗

Sales growth19.0% a year✓

Free cash flow growth—?

Return on invested capital-12.8%✗

Follow HCAT

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 1, 2026: no open-market purchases and 5 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Albert Benjamin

CEO · 2026-09-10

Tax withholding

$59K

Albert Benjamin

CEO · 2026-09-01

Tax withholding

$547

Alger Jason

Chief Financial Officer · 2026-09-01

Tax withholding

$31K

Larson-Green Julie

director · 2026-09-01

Award

9,766 shares

Landry Benjamin

General Counsel · 2026-09-01

Tax withholding

$22K

About Health Catalyst, Inc.

Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

Verdict

Business quality

Insider activity

Other filings

About Health Catalyst, Inc.